272 related articles for article (PubMed ID: 9245567)
1. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release.
Barnett CC; Moore EE; Partrick DA; Silliman CC
J Surg Res; 1997 Jul; 70(2):166-70. PubMed ID: 9245567
[TBL] [Abstract][Full Text] [Related]
2. Disparate signal transduction in neutrophil CD18 adhesion receptor expression versus superoxide generation.
Kim FJ; Moore EE; Moore FA; Koike K; Carl VS; Banerjee A
Surgery; 1994 Aug; 116(2):262-6; discussion 267. PubMed ID: 8047994
[TBL] [Abstract][Full Text] [Related]
3. Lexipafant inhibits platelet activating factor enhanced neutrophil functions.
Schwartz JD; Shamamian P; Grossi EA; Schwartz DS; Marcus SG; Steiner F; Jacobs CE; Tayyarah M; Eng K; Colvin SB; Galloway AC
J Surg Res; 1997 May; 69(2):240-8. PubMed ID: 9224389
[TBL] [Abstract][Full Text] [Related]
4. Involvement of platelet-activating factor in endotoxin-induced priming of rabbit polymorphonuclear leukocytes.
Stewart AG; Harris T
J Lipid Mediat; 1991; 3(2):125-38. PubMed ID: 1665713
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability.
Partrick DA; Moore EE; Fullerton DA; Barnett CC; Meldrum DR; Silliman CC
J Surg Res; 1999 Sep; 86(1):42-9. PubMed ID: 10452867
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products.
Vercellotti GM; Moldow CF; Wickham NW; Jacob HS
J Lipid Mediat; 1990; 2 Suppl():S23-30. PubMed ID: 1966817
[TBL] [Abstract][Full Text] [Related]
7. Primed neutrophils require phosphatidic acid for maximal receptor-activated elastase release.
Tamura DY; Moore EE; Partrick DA; Johnson JL; Zallen G; Silliman CC
J Surg Res; 1998 Jun; 77(1):71-4. PubMed ID: 9698536
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release.
Johnson JL; Moore EE; Tamura DY; Zallen G; Biffl WL; Silliman CC
J Surg Res; 1998 Apr; 76(1):91-4. PubMed ID: 9695746
[TBL] [Abstract][Full Text] [Related]
9. Cardiopulmonary bypass primes polymorphonuclear leukocytes.
Schwartz JD; Shamamian P; Schwartz DS; Grossi EA; Jacobs CE; Steiner F; Minneci PC; Baumann FG; Colvin SB; Galloway AC
J Surg Res; 1998 Mar; 75(2):177-82. PubMed ID: 9655092
[TBL] [Abstract][Full Text] [Related]
10. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
Stewart AG; Harris T; De Nichilo M; Lopez AF
Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
[TBL] [Abstract][Full Text] [Related]
11. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
Turner NC; Wood LJ; Foster M; Gueremy T
Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium.
Steel HC; Anderson R
Br J Pharmacol; 2002 May; 136(1):81-9. PubMed ID: 11976271
[TBL] [Abstract][Full Text] [Related]
13. Maximal human neutrophil priming for superoxide production and elastase release requires p38 mitogen-activated protein kinase activation.
Partrick DA; Moore EE; Offner PJ; Meldrum DR; Tamura DY; Johnson JL; Silliman CC
Arch Surg; 2000 Feb; 135(2):219-25. PubMed ID: 10668885
[TBL] [Abstract][Full Text] [Related]
14. The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components.
Shi W; Jiang R; Dobson GP; Granfeldt A; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2012 May; 143(5):1167-75. PubMed ID: 22079877
[TBL] [Abstract][Full Text] [Related]
15. Viscolin, a new chalcone from Viscum coloratum, inhibits human neutrophil superoxide anion and elastase release via a cAMP-dependent pathway.
Hwang TL; Leu YL; Kao SH; Tang MC; Chang HL
Free Radic Biol Med; 2006 Nov; 41(9):1433-41. PubMed ID: 17023270
[TBL] [Abstract][Full Text] [Related]
16. Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production.
Pinckard RN; Prihoda TJ
J Leukoc Biol; 1996 Feb; 59(2):219-28. PubMed ID: 8603994
[TBL] [Abstract][Full Text] [Related]
17. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
Stewart AG; Harris T
Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway.
Partrick DA; Moore EE; Offner PJ; Barnett CC; Barkin M; Silliman CC
Surgery; 1997 Aug; 122(2):196-202; discussion 202-3. PubMed ID: 9288123
[TBL] [Abstract][Full Text] [Related]
19. PMNs primed for superoxide release and increased CD11b expression do not sequester in normal lung.
Fontes B; Moore EE; Moore FA; Koike K; Carl V; Banerjee A
J Surg Res; 1995 Jun; 58(6):599-604. PubMed ID: 7791334
[TBL] [Abstract][Full Text] [Related]
20. Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils.
Anderson R; Goolam Mahomed A; Theron AJ; Ramafi G; Feldman C
Br J Pharmacol; 1998 Jun; 124(3):547-55. PubMed ID: 9647480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
